ADB-5'Br-BUTINACA-d9 (CRM) is intended for use as an internal standard for the quantification of ADB-5'Br-BUTINACA by GC- or LC-MS. ADB-5'Br-BUTINACA is categorized as a synthetic cannabinoid.1 This product is intended for research and forensic applications.
References:
[1].Deventer, M.H., Persson, M., Norman, C., et al.In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogsDrug Test. Anal.(2023).